Down-regulation of Dicer in hepatocellular carcinoma

Medical Oncology

Volumn 28, Issue 3, 2011, Pages 804-809

  Wu, Jin Feng ^a   Shen, Wei ^a   Liu, Nian Zhou ^b   Zeng, Gui Li ^a   Yang, Mei ^a   Zuo, Guo Qing ^a   Gan, Xiu Ni ^a   Ren, Hong ^a   Tang, Kai Fu ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Dicer; HCC; Real time PCR

Indexed keywords

DICER; MESSENGER RNA;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; TUMOR VOLUME;

ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; DOWN-REGULATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASE III; RNA, MESSENGER;

EID: 80052457673     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9520-5     Document Type: Article

References (29)

1. S Gallinger B Langer 1993 Primary and secondary hepatic malignancies Curr Opin Gen Surg 1 257 264
2. Y Fong RL Sun W Jarnagin, et al. 1999 An analysis of 412 cases of hepatocellular carcinoma at a Western center Ann Surg 229 790 800 10363892 10.1097/00000658-199906000-00005 1:STN:280:DyaK1M3ptVGlsg%3D%3D
3. D Lavanchy 2005 Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention J Clin Virol 34 Suppl 1 S1 S3 16461208 10.1016/S1386-6532(05)00384-7
4. NI Herath BA Leggett GA MacDonald 2006 Review of genetic and epigenetic alterations in hepatocarcinogenesis J Gastroenterol Hepatol 21 15 21 16706806 10.1111/j.1440-1746.2005.04043.x 1:CAS:528:DC%2BD28XhtlajsLvJ
5. MA Feitelson B Sun NL Satiroglu Tufan, et al. 2002 Genetic mechanisms of hepatocarcinogenesis Oncogene 21 2593 2604 11971194 10.1038/sj.onc.1205434 1:CAS:528:DC%2BD38Xjtlemurk%3D
6. Y Murakami T Yasuda K Saigo, et al. 2006 Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues Oncogene 25 2537 2545 16331254 10.1038/sj.onc.1209283 1:CAS:528:DC%2BD28Xjs1agu7c%3D
7. L Gramantieri M Ferracin F Fornari A Veronese, et al. 2007 Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma Cancer Res 67 6092 6099 17616664 10.1158/0008-5472.CAN- 06-4607 1:CAS:528:DC%2BD2sXnsVyqsbo%3D
8. F Meng R Henson H Wehbe-Janek, et al. 2007 MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer Gastroenterology 133 647 658 17681183 10.1053/j.gastro.2007.05.022 1:CAS:528:DC%2BD2sXhtVWqsr3L
9. H Varnholt U Drebber F Schulze 2008 MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma Hepatology 47 1223 1232 18307259 10.1002/hep.22158 1:CAS:528:DC%2BD1cXkslOjs7s%3D
10. Y Ladeiro G Couchy C Balabaud, et al. 2008 MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations Hepatology 47 1955 1963 18433021 10.1002/hep.22256 1:CAS:528:DC%2BD1cXotVagtrc%3D
11. F Fornari L Gramantieri M Ferracin, et al. 2008 MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma Oncogene 27 5651 5661 18521080 10.1038/onc.2008.178 1:CAS:528:DC%2BD1cXhtFKhsLbO
12. QW Wong RW Lung PT Law PB Lai, et al. 2008 MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1 Gastroenterology 135 257 269 18555017 10.1053/j.gastro.2008.04.003 1:CAS:528:DC%2BD1cXps1Wltbg%3D
13. J Datta H Kutay MW Nasser, et al. 2008 Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis Cancer Res 68 5049 5058 18593903 10.1158/0008-5472.CAN-07-6655 1:CAS:528:DC%2BD1cXnvFOqtLg%3D
14. W Li L Xie X He, et al. 2008 Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma Int J Cancer 123 1616 1622 18649363 10.1002/ijc.23693 1:CAS:528:DC%2BD1cXhtV2ru7%2FE
15. S Li H Fu Y Wang, et al. 2009 MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma Hepatology 49 1194 1202 19133651 10.1002/hep.22757 1:CAS:528:DC%2BD1MXkslWjsr8%3D
16. S Sekine R Ogawa R Ito, et al. 2009 Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis Gastroenterology 136 2304 2315 19272382 10.1053/j.gastro.2009.02.067 1:CAS:528:DC%2BD1MXotVequrs%3D
17. S Chiosea E Jelezcova U Chandran, et al. 2006 Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma Am J Pathol 169 1812 1820 17071602 10.2353/ajpath.2006.060480 1:CAS:528:DC%2BD28Xht12isr3P
18. RJ Flavin PC Smyth SP Finn, et al. 2008 Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients Mod Pathol 21 676 684 18327211 10.1038/modpathol.2008.33 1:CAS:528:DC%2BD1cXmtFGntrc%3D
19. X Zhang M Cairns B Rose, et al. 2009 Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland Int J Cancer 124 2855 2863 19347935 10.1002/ijc.24298 1:CAS:528:DC%2BD1MXltlCgtbY%3D
20. MG Martin JE Payton DC Link 2009 Dicer and outcomes in patients with acute myeloid leukemia (AML) Leuk Res 33 e127 19278725 10.1016/j.leukres.2009. 02.003
21. WM Merritt YG Lin LY Han, et al. 2008 Dicer, Drosha, and outcomes in patients with ovarian cancer N Engl J Med 359 25 2641 2650 19092150 10.1056/NEJMoa0803785 1:CAS:528:DC%2BD1cXhsFaltL3O
22. Y Karube H Tanaka H Osada 2005 Reduced expression of Dicer associated with poor prognosis in lung cancer patients Cancer Sci 96 111 115 15723655 10.1111/j.1349-7006.2005.00015.x 1:CAS:528:DC%2BD2MXislOhs7g%3D
23. S Chiosea E Jelezcova U Chandran, et al. 2007 Overexpression of Dicer in precursor lesions of lung adenocarcinoma Cancer Res 67 2345 2350 17332367 10.1158/0008-5472.CAN-06-3533 1:CAS:528:DC%2BD2sXitlSjsb4%3D
24. M Schöniger-Hekele C Müller M Kutilek, et al. 2001 Hepatocellular carcinoma in Central Europe: prognostic features and survival Gut 48 103 109 11115830 10.1136/gut.48.1.103
25. GA Calin C Sevignani CD Dumitru, et al. 2004 Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers Proc Natl Acad Sci USA 101 2999 3004 14973191 10.1073/pnas.0307323101 1:CAS:528:DC%2BD2cXitlWhtr8%3D
26. GA Calin CM Croce 2006 MicroRNA signatures in human cancers Nat Rev Cancer 6 857 866 17060945 10.1038/nrc1997 1:CAS:528:DC%2BD28XhtFWhs7fM
27. A Esquela-Kerscher FJ Slack 2006 Oncomirs-microRNAs with a role in cancer Nat Rev Cancer 6 259 269 16557279 10.1038/nrc1840 1:CAS:528: DC%2BD28XivVyqtrs%3D
28. BS Cobb A Hertweck J Smith, et al. 2006 A role for Dicer in immune regulation J Exp Med 203 2519 2527 17060477 10.1084/jem.20061692 1:CAS:528:DC%2BD28XhtFGqtL7E
29. L Zhang J Huang N Yang 2006 MicroRNAs exhibit high frequency genomic alterations in human cancer Proc Natl Acad Sci USA 103 9136 9141 16754881 10.1073/pnas.0508889103 1:CAS:528:DC%2BD28XmsVWjsb8%3D